Nurse Practitioner · Livingston, NJ
NPI
1497896286
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
10
Medicare group memberships
Hospitals
0
Hospital affiliations
11 Crossbrook Pl
Livingston, NJ, 07039
Phone (973) 485-6433
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,485
90 services
Medicare patients, 2024
25
Average age 76
Drug cost, 2024
$1.6M
8,380 prescriptions
Company payments, 2025
$2,037
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bela Laschiver was code 99214 (office e&m - established), 21 times for 15 patients. In total Bela Laschiver billed 90 services in 20 codes, and Medicare paid $5,485.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 21 | 15 | $91.42 | $1,920 |
| 82962 Clinical Chemistry | Office | 13 | 11 | $3.21 | $41.73 |
By year: 2022 $2,524 for 45 services; 2024 $5,485 for 90 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 13 | 11 | $3.21 | $41.73 |
Medicare prescription drug claims, 2024
In 2024, the drug Bela Laschiver prescribed most often to Medicare patients was Atorvastatin Calcium, with 419 prescriptions and refills. In total Bela Laschiver wrote 8,380 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 419 | 965 | 150 | $4,194 |
| Rosuvastatin Calcium Generic | 313 | 744 | 110 | $6,264 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 292 | 368 | 99 | $6,688 |
| Amlodipine Besylate Generic | 268 | 604 | 95 | $1,444 |
| Losartan Potassium Generic | 233 | 584 | 85 | $1,860 |
| Gabapentin Generic | 175 | 237 | 58 | $1,902 |
| Jardiance Empagliflozin | 175 | 257 | 47 | $153K |
| Ezetimibe Generic | 166 | 314 | 54 | $2,995 |
| Metoprolol Succinate Generic | 158 | 319 | 48 | $1,951 |
| Levocetirizine Dihydrochloride Generic | 156 | 304 | 53 | $908 |
| Olmesartan Medoxomil Generic | 150 | 350 | 57 | $6,186 |
| Metformin Hcl Generic | 149 | 365 | 51 | $897 |
| Levocarnitine Generic | 143 | 213 | 51 | $12K |
| Clopidogrel Clopidogrel Bisulfate | 136 | 289 | 43 | $1,317 |
| Trulicity Dulaglutide | 125 | 147 | 27 | $145K |
Brand drugs: 1,987 claims; generic drugs: 6,261 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bela Laschiver $2,037 ($2,037 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $450.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 9 | $450 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $348 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $309 |
| Madrigal Pharmaceuticals MDGL | 8 | $217 |
| GlaxoSmithKline, LLC. GSK | 10 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $93.67 |
| Novo Nordisk Inc NVO | 5 | $93.64 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $86.76 |
| Pfizer Inc. PFE | 5 | $79.1 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $63.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.